SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-064840
Filing Date
2023-05-25
Accepted
2023-05-25 20:38:05
Documents
1
Period of Report
2023-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2317083-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2317083-3_4seq1.xml 4 6082
  Complete submission text file 0001104659-23-064840.txt   7568
Mailing Address 305 MADISON AVENUE MORRISTOWN NJ 07960
Business Address 305 MADISON AVENUE MORRISTOWN NJ 07960 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERCEPT PHARMACEUTICALS, INC. 10 HUDSON YARDS, 37TH FL NEW YORK NY 10001
Business Address
Miller-Rich Nancy (Reporting) CIK: 0001735084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 23962723